Assays for noninvasive imaging of reporter gene expression

Nuclear Medicine and Biology

Volumn 26, Issue 5, 1999, Pages 481-490

  Gambhir, S S ^a,b   Barrio, J R ^b   Herschman, H R ^a,b   Phelps, M E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Lab Struct B   (United States)

Author keywords

Dopamine 2 receptor; Gene expression; Gene imaging; Reporter genes; Thymidine kinase

Indexed keywords

CYTOSINE DEAMINASE; DOPAMINE 2 RECEPTOR; FLUORINE 18; GUANOSINE DERIVATIVE; IODINE 124; IODINE 131; NUCLEOSIDE DERIVATIVE; THYMIDINE KINASE; URACIL DERIVATIVE;

ASSAY; CELL TRANSPLANTATION; CLINICAL TRIAL; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HUMAN; ISOTOPE LABELING; MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; REPORTER GENE; REVIEW; SUICIDE GENE;

EID: 0032797916     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00021-9     Document Type: Article

References (75)

1. (1998) Human gene marker/therapy clinical protocols. Hum. Gene Ther. 9, 935-976.
2. 18F]FHBG) A new potential imaging agent for viral infection and gene therapy using PET . Nucl. Med. Biol. 25:1998;175-180.
3. Alauddin M.M., Conti P.S., Mazza S.M., Hamzeh F.M., Lever J.R. Synthesis of F-18 9-[3-fluoro-1-hydroxy-2-propoxy)methyl]guanine (FHPG) for the in vivo imaging of viral infection and gene therapy with PET. J. Nucl. Med. 37:1996;193P.
4. 18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine (F-18 FHPG) in HT-29 cells. J. Nucl. Med. 38:1997;176P.
5. Alrabiah F.A., Sacks S.L. New antiherpesvirus agents Their targets and therapeutic potential . Drugs. 52:1996;17-32.
6. Arner E.S., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:1995;155-186.
7. Bading J.R., Alauddin M.M., Fissekis J.D., Kirkman E., Raman R.K., Conti P.S. Pharmacokinetics of F-18 fluorohydroxy-propoxymethylguanine (FHGP). J. Nucl. Med. 38:1997;43P.
8. Balzarini J., Bohman C., DeClercq E. Differential mechanism of cytostatic effect of (E)-5-(2-bromobinyl)-2′-deoxyruidine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J. Biol. Chem. 268:1993;6332-6337.
9. Barrio J.B., Namavari M., Phelps M.E., Satyamurthy N. Regioselective fluorination of substituted guanines with dilute F2 A facile entry of 8-fluoroguanine derivatives . J. Org. Chem. 61:1996;6084-6085.
10. 18F]fluoroethyl)spiperone In vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans . J. Cereb. Blood Flow Metab. 9:1989;830-839.
11. Barrio J.R., Namavari M., Satyamurthy N., Srinivasan A., Herschman H., Gambhir S. 8-[F-18]fluoroacyclovir An in vivo probe for gene expression with PET . J. Nucl. Med. 37:1996;193P.
12. Barrio J. R., Namavari M., Srinivasan A., Gambhir S., Cherry S., Herschman H., Phelps M. E. and Satyamurthy N. (1997) Carbon-8 radiofluorination of purines: A general approach to probe design for gene therapy in humans. In:XIIth International Symposium on Radiopharmaceutical Chemistry, Uppsala, Sweden, p. 348.
13. Black M.E., Newcomb T.G., Wilson H.-M.P., Loeb L.A. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutant for gene therapy. Proc. Natl. Acad. Sci. USA. 93:1996;3525-3529.
14. Bogdanov A., Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol. 16:1998;5-10.
15. Boyd M.R., Bacon T.H., Sutton D. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in animals. Antimicrob. Agents Chemother. 32:1988;358-363.
16. Bunzow J.R., Van Tol H.H., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature. 367:1988;783-787.
17. Chalfie M., Tu Y., Euskirchen W., Ward W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science. 263:1994;802-805.
18. Cherry S.R., Shao Y., Silverman R.W., Meadors K., Siegel S., Chatziioannou A., Young J.W., Jones W.F., Moyers J.C., Newport D., Boutefnouchet A., Farquhar T.H., Andreaco M., Paulus M.J., Binkley D.M., Nutt R., Phelps M.E. MicroPET A high resolution PET scanner for imaging small animals . IEEE Trans. Nucl. Sci. 44:1997;1161-1166.
19. De Clercq E. Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemother. 32:1993;121-132.
20. 11C-labelled raclopride, a new potent dopamine receptor antagonist Preliminary PET studies of cerebral dopamine receptors in the monkey . Int. J. Appl. Radiat. Isot. 36:1985;269-273.
21. Elion G.B. Mechanism of action and selectivity of acyclovir. Am. J. Med. 73:1982;7-13.
22. Elion G.B. Acyclovir discovery, mechanism of action, and selectivity . J. Med. Virol. 1993;2-6.
23. Enochs W.S., Petherick P., Bogdanova A., Mohr U., Weissleder R. Paramegnetic metal scavenging by melanin MR imaging . Radiology. 204:1997;417-423.
24. Field A.K., Davies M.E., DeWitt C., Perry H.C., Liou R., Germershausen J., Karkas J.D., Ashton W.T., Johnston D.B.R., Tolman R. 9-(-2-hydroxy-1-hydroxymethyl)ethoxy] methyl)guanine A selective inhibitor of herpes group viruses replication . Proc. Natl. Acad. Sci. USA. 80:1983;4139-4143.
25. Gallardo H.F., Tan C., Sadelain M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphyocytes. Gene Ther. 4:1997;1115-1119.
26. Gambhir S.S., Barrio J., Wu L., Iyer M., Namavari M., Satyamurthy N., Bauer E., Parrish C., MacLaren D., Borghei A., Berk A., Cherry S., Phelps M.E., Herschman H. Imaging of adenoviral directed herpes simplex virus type 1 thymidine kinase gene expression in mice with ganciclovir. J. Nucl. Med. 39:1998;2003-2011.
27. Gambhir S.S., Barrio J.R., Bauer E., Iyer M., Namavari M., Satyamurthy N., Shah P., Toyokuni T., Wu L., Berk A.J., Phelps M.E., Herschman H. Radiolabeled penciclovir A new reporter probe with improved imaging properties over ganciclovir for imaging herpes-simplex virus type 1 thymidine kinase reporter gene expression [abstract] . J. Nucl. Med. 39:1998;53P.
28. Gambhir S.S., Barrio J.R., Phelps M.E., Iyer M., Namavari M., Satyamurthy N., Wu L., Green L.A., Bauer E., MacLaren D.C., Nguyen K., Berk A.J., Cherry S.R., Herschman H.R. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. (USA). 96:1999;2333-2338.
29. Gerolami R., Cardoso J., Bralet M.P., Cuenod C.A., Clement O., Tran P.L., Brechot C. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther. 5:1998;896-904.
30. Green L.A., Gambhir S.S., Barrio J.R., Bauer E., Nguyen K., Namavari M., Cherry S.R., Herschman H., Phelps M.E. Tracer kinetic modeling of 8-(F18)-fluoroganciclovir PET data A new tracer for measuring reporter gene expression . J. Nucl. Med. 39:(suppl.):1998;10P.
31. Haberkorn U., Altmann A., Morr I., Germann C., Oberdorfer F., van Kaick G. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir. J. Nucl. Med. 38:1997;1048-1054.
32. Haberkorn U., Altmann A., Morr I., Knopf K.-W., Germann C., Haeckel R., Oberdorfer F. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells Uptake of specific substrates . J. Nucl. Med. 38:1997;287-294.
33. Haberkorn U., Bellemann M., Gerlach L., Morr I., Trojan H., Brix G., Altmann A., Doll J., van Kaick G. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther. 5:1998;880-887.
34. Haberkorn U., Khazaie K., Morr I., Altmann A., Müller M., van Kaick G. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. Nucl. Med. Biol. 25:1998;367-373.
35. 3H-5-fluorocytosine . J. Nucl. Med. 37:1996;87-94.
36. Haider N., Iyer R.R., Narula J. Topics in molecular biology Techniques and methods . J. Nucl. Cardiol. 5:1998;343-354.
37. Herz J., Gerard R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol in normal mice. Proc. Natl. Acad. Sci. USA. 90:1993;2812-2816.
38. Jacobs W.R., Barletta R.G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G.J., Hatfull G.F., Bloom B.R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 260:1993;819-822.
39. Kessler R.M., Ansari M.S., de Paulis T., Schmidt D.E., Clanton J.A., Smith H.E., Manning R.G., Gillespie D., Ebert M.H. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamines. J. Nucl. Med. 32:1991;1593-1600.
40. Levenson V.V., Transue E.D., Roninson I.B. Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers. Hum. Gene Ther. 9:1998;1233-1236.
41. MacLaren D.C., Gambhir S.S., Satyamurthy N., Barrio J.R., Sharfstein S., Toyokuni T., Wu L., Berk A.J., Cherry S.R., Phelps M.E., Herschman H.R. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6:1999;785-791.
42. Miller N., Vile R. Targeted vectors for gene therapy. FASEB J. 9:1995;190-199.
43. Misteli T., Spector D. Applications of the green fluorescent protein in cell biology and biotechnology. Nat. Biotechnol. 15:1997;961-964.
44. 18F]Fluoro-1-hydroxy-2-propoxy)methyl}guanine . Bioorganic Med. Chem. Lett. 7:1997;1879-1882.
45. 18F)fluoro-3-hydroxy-2-propoxy)methyl) guanine . J. Labelled Compd. Radiopharm. 37:1995;193-195.
46. 125I]iodovinyl-2′-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy. J. Med. Chem. 40:1997;2184-2190.
47. Neve K.A., Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L. Pivotal role for spartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39:1991;733-739.
48. Nishiyama T., Kawamura Y., Kawamoto K., Matsumura H., Yamamoto N., Ito T., Ohyama A., Katsuragi T., Sakai T. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res. 45:1985;1753-1761.
49. No D., Yao T.P., Evans R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;3346-3351.
50. Palmer K.A., De Giovanni-Donnelly R. Characterization of thymidine kinase in L5178Y mouse lymphoma cells. Toxicol. Ind. Health. 1:1985;1-12.
51. Pentlow K.S., Graham M.C., Lambrecht R.M., Daghighian F., Bacharach S.L., Bendriem B., Finn R.D., Jordan K., Kalaigian H., Karp J.S., Robeson W.R., Larson S.M. Quantitative imaging of iodine-124 with PET. J. Nucl. Med. 37:1996;1557-1562.
52. Price R., Cardle K., Watanabe K. The use of antiviral drugs to image herpes encephalitits. Cancer Res. 43:1983;3619-3627.
53. Rolland A.P. From genes to gene medicines Recent advances in nonviral gene delivery . Crit. Rev. Ther. Drug Carrier Syst. 15:1998;143-198.
54. Saito Y., Price R.W., Rottenberg D.A., Fox J.J., Su T.-L., Watanabe K.A., Philips F.A. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with radiolabeled antiviral drug. Science. 217:1982;1151-1153.
55. Saito Y., Rubenstein R., Price R., Fox J.J., Watanabe K.A. Diagnostic imaging of herpes simplex virus encephaliltis using antiviral drug Autoradiographic assessment in animal model . Ann. Neurol. 15:1984;548-558.
56. Smee D.F., Boehme R., Chernow M., Binko B.P., Matthews T.R. Intracellular metabolism and enzymatic phosphorylation of 9-(1, 3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells. Biochem. Pharmacol. 34:1985;1049-1056.
57. Smith A.E. Viral vectors in gene therapy. Annu. Rev. Microbiol. 49:1995;807-838.
58. Srinivasan A., Gambhir S.S., Green L.A., Cherry S.R., Sharfstein S., Barrio J.R., Satyamurthy N., Namavari M., Wu L., Berk A.J., Phelps M.E., Herschman H. A PET reporter gene (PRG)/PET reporter probe (PRP) technology for repeatedly imaging gene expression in living animals. J. Nucl. Med. 37:1996;107P.
59. Strange P.G. Aspects of the structure of the D2 dopamine receptor. Trends Neurosci. 13:1990;373-378.
60. Stratford-Perricaudet L.D., Levrero M., Chasse J.-F., Perricaudet M., Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:1990;241-256.
61. Tjuvajev J.G., Avril N., Oku T., Sasajima T., Miyagawa T., Joshi R., Safer M., Beattie B., DiResta G., Daghighian F., Augensen F., Koutcher J., Zweit J., Humm J., Larson S.M., Finn R., Blasberg R. Imaging herpes virus thymidine kinase gene gransfer and expression by positron emission tomography. Cancer Res. 58:1998;4333-4341.
62. Tjuvajev J.G., Finn R., Watanabe K., Joshi R., Oku T., Kennedy J., Beattie B., Koutcher J., Larson S., Blasberg R.G. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression A potential method for monitoring clinical gene therapy . Cancer Res. 56:1996;4087-4095.
63. Tjuvajev J.G., Joshi R., Lindsley L., Balatoni J., Finn R., Larson S., Sadelain M., Blasberg R. Noninvasive imaging of HSV1-tk marker gene with FIAU for monitoring transfer and expression of other therapeutic genes by multi-gene delivery vectors. J. Nucl. Med. 39:1998;130P.
64. Tjuvajev J.G., Stockhammer G., Desai R., Uehara H., Gansbacher B., Watanabe K., Blasberg R. Imaging gene transfer and expression in vivo. Cancer Res. 55:1995;6121-6135.
65. Tjuvajev J.G., Stockhammer G., Desai R., Uehara H., Watanabe H., Gansbacher B., Blasberg R.G. Imaging the expression of transfected genes in vivo. Cancer Res. 55:1995;6126-6132.
66. Tovell D.R., Samuel J., Mercer J.R., Misra H.K., Xu L., Wiebe L.I., Tyrrell D.L., Knaus E.E. The in vitro evaluation of nucleoside analogues as probes for use in the non-invasive diagnosis of herpes simplex encephalitis. Drug. Des. Delivery. 3:1988;213-221.
67. Vere Hodge R.A., Perkins R.M. Mode of action of 9-(4-hudroxy-3-hudroxymethyl-but-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob. Agents Chemother. 33:1989;223-229.
68. Verma I.M., Somia N. Gene therapy - Promises, problems and prospects. Nature. 389:1997;239-242.
69. Wagner H.N.J., Burns H.D., Dannals R.F., Wong D.R., Langstrom B., Duelfer T., Frost J.J., Ravert H.T., Links J.M., Rosenbloom S.B., Lukas S.E., Kramer A.V., Kuhar M.J. Imaging dopamine receptors in the human brain by positron tomography. Science. 221:1983;1264-1266.
70. Wallace P.M., MacMaster J.F., Smith V.F., Kerr D.E., Senter P.D., Cosand W.L. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res. 54:1994;2719-2723.
71. Wang J., Eriksson S. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′deoxy-2′-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob. Agents Chemother. 40:1996;1555-1557.
72. Weissleder R., Simonova M., Bogdanova A., Bredow S., Enochs W., Bogdanov A.J. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 204:1997;425-429.
73. Wiebe L.I., Knaus E., Morin K.W. HSV-thymidine kinase. A molecular target for transfection imaging in gene therapy of cancer [abstract]. Antiviral Res. 26:1995;A307.
74. Woodward R., Roley C., Daniell S., Naylor L.H., Strange P.G. Investigation of the role of conserved serine residues in the long form of the rat D2 dopamine receptor using site-directed mutagenesis. J. Neurochem. 66:1996;394-402.
75. Yang L., Hwang R., Pandit L., Gordon E.M., Anderson W.F., Parekh D. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann. Surg. 224:1996;405-414.